Unlocking the Value of Your Data
March 10, 2020 All Industries Growth
In this episode of Looking Ahead, Al Dominick is joined by Lindsey Androski, Vice President & Head of Strategic Partnering at Roivant Sciences. They discuss why and how companies focus on the value, and not the volume, of information when adopting a data-driven approach to decision making.
Three AI Trends To Keep In Mind
March 9, 2020 All Industries Corporate Governance
The number of companies using artifiicial intelligence within at least one department of their organization grew by nearly 25% last year. If your firm is just getting started on testing AI, here are three key considerations.
Sprint, T-Mobile Merger Could Signal A New Acquisition Wave
March 9, 2020 Technology M&A
The likely approval of the $26 billion merger of T-Mobile US and Sprint Corp. could force the telecom sector into a third stage of acquisitions. This time, mobile purchasing partners could be cable companies, according to CNBC.
SEC To Keep The CBOE ‘Speed Bump’ Free
March 9, 2020 All Industries Regulatory
The CBOE sought to prevent high frequency traders from profiting off of stale prices by adding a 4-milisecond delay in certain trades within an exchange. The SEC denied the request, potentially slowing the push for similar initiatives.
Avoiding Surprises In The Board Room
March 9, 2020 Healthcare Corporate Governance
The New York Times has reported that executives at Walgreens Boots Alliance asked consultants to remove findings from an internal report that included complaints from its employees. For a better way of making sure information isn’t hidden from the board, look towards this technology darling.
Upcoming Event
Transactions 2020 | Health
October 5, 2020 New York New York
Be it a strategic merger or financial acquisition, the healthcare industry has experienced record-setting deal volume over the last few years. Given transactions within the pharma and biotech space to disruptions in healthcare services, we continue to see financial sponsors seeking out new paths to grow. While some believe the pace of consolidation will increase, others wonder if pricing has become too expensive and appetites for deals, overly exuberant. So is now the time to buy, sell or go public? At DirectorCorps’ annual Transactions Conference, we explore these potential paths with top executives and members of the boards of leading healthcare organizations.